CYP2D6 - cytochrome P450 family 2 subfamily D member 6 Gene
Also Known as CPD6; CYP2D; CYP2DL1; CYPIID6; P450C2D; P450DB1; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; P450-DB1
Species: Homo sapiens
About CYP2D6
This gene has 4 transcripts (splice variants), 1 gene allele, 293 orthologues, 15 paralogues and is associated with 1 phenotype. Biased expression in liver (RPKM 40.1), small intestine (RPKM 14.6) and 2 other tissues.
Summary
This gene encodes a member of the Cytochrome P450 superfamily of Enzymes. The Cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of Cholesterol, Steroids and Other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in Other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
CYP2D6 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_000106.6 | NP_000097.3 | cytochrome P450 2D6 isoform 1 |
| NM_001025161.3 | NP_001020332.2 | cytochrome P450 2D6 isoform 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables anandamide 11,12 epoxidase activity |
IDA
IDA: Inferred from direct assay
|
21289075 | GOA |
| enables anandamide 14,15 epoxidase activity |
IDA
IDA: Inferred from direct assay
|
21289075 | GOA |
| enables anandamide 8,9 epoxidase activity |
IDA
IDA: Inferred from direct assay
|
21289075 | GOA |
| enables heme binding |
IDA
IDA: Inferred from direct assay
|
16352597 | GOA |
| enables monooxygenase activity |
IDA
IDA: Inferred from direct assay
|
15327587 | GOA |
| enables oxidoreductase activity |
IDA
IDA: Inferred from direct assay
|
15039299 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in mitochondrion |
IDA
IDA: Inferred from direct assay
|
19438707 | GOA |
CYP2D6 Protein Structure
p450: Cytochrome P450 (34 - 493)
- 0
- 100
- 200
- 300
- 400
- 497 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytochrome P450 2D6 |
|
CYP2D6 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P83639 | Cytochrome P450 2D6 Antibody (YA3384) | WB, IHC-P, ICC/IF, FC | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Drug Metabolism, Poor, Cyp2d6-Related |
|
|
| Neuroleptic Malignant Syndrome |
|
|
| Autoimmune Hepatitis |
|
|
| Multiple Chemical Sensitivity |
|
|
| Gastroparesis |
|
|
| Substance Abuse |
|
|
| Anxiety |
|
|
| Galactorrhea |
|
|
| Plasmodium Ovale Malaria |
|
|
| Tardive Dyskinesia |
|
|
| Major Depressive Disorder |
|
|
| Ichthyosis, Congenital, Autosomal Recessive 6 |
|
|
| Amelogenesis Imperfecta, Type Ib |
|
|
| Plasmodium Vivax Malaria |
|
|
| Coumarin Resistance |
|
|
| Serotonin Syndrome |
|
|
| Obsessive-Compulsive Disorder |
|
|
| Impotence |
|
|
| Space Motion Sickness |
|
|
| Parkinsonism |
|
|
| Acetaminophen Metabolism |
|
|
| Amelogenesis Imperfecta, Type Ie |
|
|
| Attention Deficit-Hyperactivity Disorder |
|
|
| Dementia, Lewy Body |
|
|
| Drug-Induced Hepatitis |
|
|
| Opioid Abuse |
|
|
| Bipolar I Disorder |
|
|
| Female Stress Incontinence |
|
|
| Neonatal Abstinence Syndrome |
|
|
| Parkinson Disease, Late-Onset |
|
|
| Thiopurines, Poor Metabolism Of, 1 |
|
|
| Progesterone-Receptor Positive Breast Cancer |
|
|
| Liver Disease |
|
|
| Adjustment Disorder |
|
|
| Psychotic Disorder |
|
|
| Estrogen-Receptor Positive Breast Cancer |
|
|
| Laryngeal Squamous Cell Carcinoma |
|
|
| Schizoaffective Disorder |
|
|
| Schizophrenia |
|
|
| Basal Cell Carcinoma |
|
|
| Glucosephosphate Dehydrogenase Deficiency |
|
|
| Malaria |
|
|
| Delusional Disorder |
|
|
| Severe Cutaneous Adverse Reaction |
|
|
| Dementia |
|
|
| Motion Sickness |
|
|
| Motor Neuron Disease |
|
|
| Hypertrophy Of Tongue Papillae |
|
|
| Psychosexual Disorder |
|
|
| Movement Disease |
|
|
| Pain Agnosia |
|
|
| Conidiobolomycosis |
|
|
| Agnosia |
|
|
| Withdrawal Disorder |
|
|
| Mental Depression |
|
|
| Generalized Anxiety Disorder |
|
|
| Breast Cancer |
|
|
| Hypertension, Essential |
|
|
| Migraine With Or Without Aura 1 |
|
|
| Dysthymic Disorder |
|
|
| Dystonia |
|
|
| Outlet Dysfunction Constipation |
|
|
| Transvestism |
|
|
| Lung Cancer |
|
|
| Joubert Syndrome 1 |
|
|
| Epilepsy |
|
|
| Colorectal Cancer |
|
|
| Gilbert Syndrome |
|
|
| Akinetopsia |
|
|
| Specific Developmental Disorder |
|
|
| Systemic Lupus Erythematosus |
|
|
| Constipation |
|
|
| Bilirubin Metabolic Disorder |
|
|
| Amelogenesis Imperfecta |
|
|
| Long Qt Syndrome |
|
|
| Alzheimer Disease, Familial, 1 |
|
|
| Type 2 Diabetes Mellitus |
|
|
| Nervous System Disease |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Rattus norvegicus | CYP2D6 | RGD | RGD:620640 |
| Others | CYP2D6 | NCBI |